Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
17 Mar - 16 June 1969
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable, well-documented study report which meets basic scientific principles.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1969
Report date:
1969

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
Rats were fed a diet containing 5, 10 and 25% oleic acid over a time period of 84 days.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Oleic acid
EC Number:
204-007-1
EC Name:
Oleic acid
Cas Number:
112-80-1
Molecular formula:
C18H34O2
IUPAC Name:
octadec-9-enoic acid

Test animals

Species:
rat
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River
- Weight at study initiation: 115-116 g
- Housing: individually in wire bottomed steel cages, animals were also ear punched
- Diet (e.g. ad libitum): ad libitum

Administration / exposure

Route of administration:
oral: feed
Vehicle:
not specified
Details on oral exposure:
DIET PREPARATION
- Rate of preparation of diet (frequency): weekly
- Mixing appropriate amounts with (Type of food): standard rat ration


Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
84 days
Frequency of treatment:
no data
Doses / concentrationsopen allclose all
Dose / conc.:
5 other: %
Remarks:
equivalent to ca. 2500 mg/kg bw/day
(calculated based on the average daily food consumption of 5 g/100 g bw (WHO, 1987))
Dose / conc.:
10 other: %
Remarks:
equivalent to ca. 5000 mg/kg bw/day
(calculated based on the average daily food consumption of 5 g/100 g bw (WHO, 1987))
Dose / conc.:
25 other: %
Remarks:
equivalent to ca. 12500 mg/kg bw/day
(calculated based on the average daily food consumption of 5 g/100 g bw (WHO, 1987))
No. of animals per sex per dose:
10
Control animals:
yes

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
- Cage side observations: abnormal reactions and mortality


BODY WEIGHT: Yes
- Time schedule for examinations: weekly for five rats of each sex of each group


FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes
- Food consumption for each animal determined: collected weekly for five rats of each sex in all groups

HAEMATOLOGY: Yes
- Time schedule for collection of blood: at day 84 of feeding
- How many animals: five rats of each sex in the control and 25% dosage group and three rats of each sex in the 10% group
- Parameters checked: hematocrit, hemaglobin concentration, erythrocyte count, total and differential leukocyte count, reticulocyte count, prothrombin time and cell index (MCV, MCH, MCHC)


CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at day 84 of feeding
- How many animals: five rats of each sex in the control and 25% dosage group and three rats of each sex in the 10% group
- Parameters checked: fasted serum glucose, total cholesterol, blood urea nitrogen, total protein, serum alkaline phosphatase (SAP), serum glutamic-pyruvic transaminase (SGPT), serum glutamic-oxalacetic tranaminase (SGOT), A/G ratio and Icterus index


URINALYSIS: Yes
- Time schedule for collection of urine: at day 84 of feeding
- Parameters checked: protein, glucose, pH, specific gravity and microscopic elements


NEUROBEHAVIOURAL EXAMINATION: Yes


Sacrifice and pathology:
GROSS PATHOLOGY: Yes, all animals that died during the study were examined grossly unless examination was precluded by post-mortem autolysis. At the end of the 90-day feeding period, all surviving rats were necropsied, and organ weights were recorded for liver, kidneys, spleen, gonads, adrenals, heart, thymus and brain.

HISTOPATHOLOGY: Yes, histopathological examinations were conducted on: brain, spinal cord, pituitary, thyroid, parathyroid, thymus, salivary glands, stomach, small and large intestines, liver, pancreas, kidneys, adrenals, spleen, heart, trachea, lungs, aorta, testes, seminal vesicle, ovary, uterus, prostate, urinary bladder, lymph nodes, peripheral nerve, bone marrow, skeletal muscle, bone (femur), eye and optic nerve.
Statistics:
Organ and body weights were analyzed using analysis of variance and a t-test.

Results and discussion

Results of examinations

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
3 animals died due to blood collection trauma
Mortality:
mortality observed, treatment-related
Description (incidence):
3 animals died due to blood collection trauma
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
slightly higher final body weights in treatment groups, not statistically significant
Food consumption and compound intake (if feeding study):
effects observed, treatment-related
Description (incidence and severity):
slightly decreased in treatment groups, non-adverse
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Behaviour (functional findings):
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
effects observed, treatment-related
Description (incidence and severity):
significant differences in organ/body weight ratios except for kidneys, adrenal glands and brain, non-adverse
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
no effects observed
Details on results:
CLINICAL SIGNS AND MORTALITY
Two control animals died on day 84. These deaths were related to blood collection. One female animal from the 10% dosage group also died from blood collection trauma. There were no other mortalities or clinical signs of toxicity.


BODY WEIGHT AND WEIGHT GAIN
The test animals had slightly higher final body weights than controls, but the differences were not statistically significant.

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
Food consumption among test animals was slightly lower than among the control animals.

HAEMATOLOGY
There were no outstanding differences in hematologic parameters among test and control animals

CLINICAL CHEMISTRY
There were no outstanding differences in clinical chemistry parameters among test and control animals

URINALYSIS
There were no outstanding differences in urinalysis parameters among test and control animals

NEUROBEHAVIOUR
No abnormal behavioural reactions were noted in the study.

ORGAN WEIGHTS
There were no significant differences in organ/body weight ratios except for kidneys, adrenal glands and brain. For these three organs, female test animals showed a higher organ/body weight ratio than control animals. All of these differences could be attributed to the slightly higher body weights observed in every test group rather than a deleterious effect of the test material. The absence of any abnormalities of these organs upon histopathologic examination would support this conclusion.

GROSS PATHOLOGY
No abnormalities were noted at gross examination.

HISTOPATHOLOGY: NON-NEOPLASTIC
Some minor histopathologic changes were noted among both the test and control animals, specifcially involving lesions in the trachea and lungs. These changes were judged to be due to spontaneous disease (potential pneumonia), and not related to the test material.

Effect levels

open allclose all
Dose descriptor:
NOAEL
Effect level:
>= 25 other: %
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: NOAEL corresponding to the highest dose tested
Dose descriptor:
NOAEL
Effect level:
>= 12 500 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: NOAEL corresponding to the highest dose tested

Target system / organ toxicity

Critical effects observed:
no

Applicant's summary and conclusion

Conclusions:
Oleic acid is practically nontoxic to rats in a repeated dose study when given doses of up to 25% in the diet. The NOAEL was ≥25% equivalent to ≥12500 mg/kg bw/day.